ProCell Therapeutics R&D and Labs
ProCellTerraputics aims to be a first-class company in biopharmaceuticals with its macromolecule intracellular transfer technology (MITT), an innovative source technology.
Headquarters:
Seoul, South Korea
Founded Date:
20.12.2005
Employees Number:
1—10
Estimated Revenue:
$0
Register and Claim Ownership